{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T22:25:01Z","timestamp":1788387901736,"version":"build-2803163510"},"reference-count":22,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T00:00:00Z","timestamp":1682553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>The Watchman FLX is a novel device for transcatheter left atrial appendage occlusion (LAAO) specifically designed to improve procedural performance in more complex anatomies with a better safety profile. Recently, small prospective non-randomized studies have shown good procedural success and safety compared with previous experiences. Results from large multicenter registries are needed to confirm the safety and efficacy of the Watchman FLX device in a real-world setting.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Italian FLX registry is a retrospective, non-randomized, multicentric study across 25 investigational centers in Italy including consecutive patients undergoing LAAO with the Watchman FLX between March 2019 and September 2021 (N\u2009=\u2009772). The primary efficacy outcome was the technical success of the LAAO procedure (peri-device flow \u2264\u20095 mm) as assessed by intra-procedural imaging. The peri-procedural safety outcome was defined as the occurrence of one of the following events within 7 days after the procedure or by hospital discharge: death, stroke, transient ischemic attack, major extracranial bleeding (BARC type 3 or 5), pericardial effusion with tamponade or device embolization.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 772 patients were enrolled. The mean age was 76\u2009\u00b1\u20098 with a mean CHA2DS2-VASc score of 4.1\u2009\u00b1\u20091.4 and a mean HAS-BLED score of 3.7\u2009\u00b1\u20091.1. Technical success was achieved in 772 (100%) patients with the first device implanted in 760 (98.4%) patients. A peri-procedural safety outcome event occurred in 21 patients (2.7%) with major extracranial bleeding being the most common (1.7%). No device embolization occurred. At discharge 459 patients (59.4%) were treated with dual antiplatelet therapy (DAPT).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The Italian FLX registry represents the largest multicenter retrospective real-world study reporting periprocedural outcome of LAAO with the Watchman FLX device, resulting in a procedural success rate of 100% and a low incidence of peri-procedural major adverse events (2.7%).<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2023.1115811","type":"journal-article","created":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T05:37:21Z","timestamp":1682573841000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Periprocedural outcome in patients undergoing left atrial appendage occlusion with the Watchman FLX device: The ITALIAN-FLX registry"],"prefix":"10.3389","volume":"10","author":[{"given":"Sergio","family":"Berti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto Ranieri","family":"De Caterina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmelo","family":"Grasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavino","family":"Casu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Giacchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Pagnotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Maremmani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizio","family":"Mazzone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Limite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Tomassini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Greco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Rita","family":"Romeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Caramanno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"Fassini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Geraci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Chiarito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Tondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corrado","family":"Tamburino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Contarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,4,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European association for cardio-thoracic surgery (EACTS)","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.4244\/EIJY19M08_01","article-title":"EHRA\/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion\u2014an update","volume":"15","author":"Glikson","year":"2020","journal-title":"EuroIntervention"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1001\/jama.2014.15192","article-title":"Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation a randomized clinical trial","volume":"312","author":"Reddy","year":"2014","journal-title":"JAMA"},{"key":"B4","author":"Holmes","year":""},{"key":"B5","doi-asserted-by":"publisher","first-page":"2795","DOI":"10.1016\/j.jacc.2020.08.089","article-title":"Left atrial appendage closure versus oral anticoagulants in atrial fibrillation: a meta-analysis of randomized trials","volume":"76","author":"Turagam","year":"2020","journal-title":"J Am Coll Cardiol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1016\/j.jacc.2019.12.040","article-title":"The NCDR left atrial appendage occlusion registry","volume":"75","author":"Freeman","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e007257","DOI":"10.1161\/CIRCEP.119.007257","article-title":"EWOLUTION Of watchman left atrial appendage closure to patients with contraindication to oral anticoagulation","volume":"12","author":"Turagam","year":"2019","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1161\/CIRCULATIONAHA.120.050117","article-title":"Primary outcome evaluation of a next-generation left atrial appendage closure device: results from the PINNACLE FLX trial","volume":"143","author":"Kar","year":"2021","journal-title":"Circulation"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1016\/j.jacep.2020.06.028","article-title":"The watchman FLX device: first European experience and feasibility of intracardiac echocardiography to guide implantation","volume":"6","author":"Korsholm","year":"2020","journal-title":"JACC Clin Electrophysiol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"240","DOI":"10.33963\/KP.15172","article-title":"Watchman FLX: the initial Polish experience with a new device for left atrial appendage occlusion","volume":"78","author":"Grygier","year":"2020","journal-title":"Kardiol Pol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2732","DOI":"10.1016\/j.jcin.2020.06.056","article-title":"Results with the New Watchman FLX Left atrial appendage occlusion device","volume":"13","author":"Cruz-Gonz\u00e1lez","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.hrthm.2022.02.007","article-title":"Procedural and short-term follow-up outcomes of Amplatzer Amulet occluder versus Watchman FLX device: A meta-analysis","volume":"19","author":"Della Rocca","year":"2022","journal-title":"Heart Rhythm"},{"key":"B13","doi-asserted-by":"publisher","first-page":"62","DOI":"10.5114\/aic.2017.66188","article-title":"The watchman FLX\u2014a new device for left atrial appendage occlusion\u2014design, potential benefits and first clinical experience","volume":"13","author":"Grygier","year":"2017","journal-title":"Postepy Kardiol Interwencyjnej"},{"key":"B14","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.jcin.2019.08.054","article-title":"Expert recommendations on cardiac computed tomography for planning transcatheter left atrial appendage occlusion","volume":"13","author":"Korsholm","year":"2020","journal-title":"JACC Cardiovasc Interv."},{"key":"B15","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.iccl.2017.12.004","article-title":"Cardiac computed tomography for left atrial appendage occlusion: acquisition, analysis, advantages, and limitations","volume":"7","author":"Korsholm","year":"2018","journal-title":"Interv Cardiol Clin"},{"key":"B16","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.echo.2017.09.014","article-title":"Left atrial appendage occlusion\/exclusion: procedural image guidance with transesophageal echocardiography","volume":"31","author":"Vainrib","year":"2018","journal-title":"J Am Soc Echocardiogr"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the bleeding academic research consortium","volume":"123","author":"Mehran","year":"2011","journal-title":"Circulation"},{"key":"B18","doi-asserted-by":"publisher","first-page":"103","DOI":"10.4244\/EIJV12I1A18","article-title":"Percutaneous left atrial appendage occlusion: the Munich consensus document on definitions, endpoints and data collection requirements for clinical studies","volume":"12","author":"Tzikas","year":"2016","journal-title":"EuroIntervention"},{"key":"B19","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/eurheartj\/ehq406","article-title":"Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the valve academic research consortium","volume":"32","author":"Leon","year":"2011","journal-title":"Eur Heart J"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e022274","DOI":"10.1161\/JAHA.121.022274","article-title":"Left atrial appendage occlusion for stroke prevention in nonvalvular atrial fibrillation","volume":"10","author":"Collado","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e590","DOI":"10.4244\/EIJ-D-18-00344","article-title":"Left atrial appendage occlusion with the AMPLATZER amulet device: one-year follow-up from the prospective global amulet observational registry","volume":"14","author":"Landmesser","year":"2018","journal-title":"EuroIntervention"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1016\/j.hrthm.2013.08.025","article-title":"Left atrial appendage closure followed by 6 weeks of antithrombotic therapy: a prospective single-center experience","volume":"10","author":"Chun","year":"2013","journal-title":"Heart Rhythm"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2023.1115811\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T05:37:23Z","timestamp":1682573843000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2023.1115811\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,27]]},"references-count":22,"alternative-id":["10.3389\/fcvm.2023.1115811"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2023.1115811","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,27]]},"article-number":"1115811"}}